Recalcitrant pyoderma gangrenosum: Treatment with thalidomide

Journal of the American Academy of Dermatology

Volumn 38, Issue 3, 1998, Pages 490-491

  Hecker, M S ^a   Lebwohl, M G ^a  

^a Box 1048   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLOFAZIMINE; CYCLOSPORIN; DAPSONE; ISOTRETINOIN; STEROID; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG APPROVAL; DRUG EFFICACY; ENTERITIS; ERYTHEMA NODOSUM LEPROSUM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIMB DEFECT; MALE; ORAL DRUG ADMINISTRATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PUSTULE; PYODERMA GANGRENOSUM; SKIN ULCER; TOPICAL DRUG ADMINISTRATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0031937242     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(98)70513-4     Document Type: Article

References (14)

1. GW Mellen M. Katzenstein The saga of thalidomide: neuropathy to embryopathy, with case reports and congenital abnormalities N Engl J Med 267 1962 1184 1193
2. PF D’Arcy JP. Griffin Thalidomide revisited Adverse Drug React Toxicol Rev 13 2 1994 65 76
3. RL Barnhill AC. McDougall Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions J Am Acad Dermatol 7 1982 317 323
4. PM Fullerton M. Kremer Neuropathy after intake of thalidomide (Distexal) Br Med J 1 1961 130
5. J. Sheskin Thalidomide in the treatment of lepra reactions Clin Pharmacol Ther 6 1965 303
6. RJ Powell JM. Gardner-Medwin Guidelines for the clinical use and dispensing of thalidomide Post Grad Med J 70 1994 901 904
7. PY Venencie J-H. Saurat Pyoderma gangrenosum chez un enfant: traitement par la thalidomide Ann Pediatr 1 1982 67 69
8. MH Rustin JJ Gilkes TW. Robinson Pyoderma gangrenosum associated with Behçet’s disease: treatment with thalidomide J Am Acad Dermatol 23 1990 941 944
9. CS Munro NH. Cox Pyoderma gangrenosum associated with Behçet’s syndrome: response to thalidomide Clin Exp Dermatol 13 1988 408 410
10. K Hellman DI Duke DF. Tucker Prolongation of skin homograft survival by thalidomide Br Med J 2 1965 687 689
11. HP. Koch Thalidomide and congeners as anti-inflammatory agents Prog Med Chem 22 1985 165 242
12. AL Moreira EP Sampaio A Zmuidzinas P Frindt KA Smith G. Kaplan Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation J Exp Med 177 1993 1675 1680
13. EP Sampaio EN Sarno R Galilly ZA Cohen G. Kaplan Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes J Exp Med 173 1991 699 703
14. M Faure J Thivolet M. Gaucherand Inhibition of PMN leukocytes: chemotaxis by thalidomide Arch Dermatol Res 269 1980 275 280